Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × HCC × Radiofrequency Ablation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Hepatocellular 31 Liver Neoplasms 16 Neoplasm Metastasis 15 Colorectal Neoplasms 11 Cholangiocarcinoma 11 Pancreatic Neoplasms 8 Lung Neoplasms 8 Colonic Neoplasms 7 Breast Neoplasms 7 Barrett Esophagus 7 Carcinoma, Non-Small-Cell Lung 6 Recurrence 5 Thyroid Nodule 4 Thyroid Neoplasms 4 Rectal Neoplasms 4 Pain 4 Neoplasms 4 Esophageal Neoplasms 4 Carcinoma, Renal Cell 4 Kidney Neoplasms 3 Biliary Tract Neoplasms 3 Agnosia 3 Thyroid Diseases 2 Thyroid Cancer, Papillary 2 Prostatic Neoplasms 2 Leiomyoma 2 Hyperaldosteronism 2 Cancer Pain 2 Bile Duct Neoplasms 2 Uterine Cervical Neoplasms 1

Interventions

nimotuzumab 1 atezolizumab 1 Tirapazamine 1 Sorafenib 1 Radiotherapy 1 Radiosurgery 1 Radiofrequency Ablation 1 Immune Checkpoint Inhibitors 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01470495 2017-03-28

REPEAT

Southwest Hospital, China

Phase NA Unknown

HCC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡